counterfeit semaglutide legal status fda ⚠️ CHICAGO CONSUMER ALERT: The has confirmed that versions of popular GLP-1 weight-loss drugs—including (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are Tips to identify FDA-approved medicines

Redirect people to safety and educational resources for weight loss products when they search for those products

Originally approved to help people with Type 2 diabetes, the class of medications known as GLP-1 agonists and dual GIP/GLP-1s quickly acquired a reputation for helping people shed stubborn pounds

Side Effect Profile Both medications have similar side effect profiles, with gastrointestinal issues being the most common: Nausea Diarrhea Vomiting Constipation Abdominal pain While the incidence of side effects is generally similar between the two medications, some studies suggest that tirzepatide may have a slightly higher rate of gastrointestinal side effects, particularly at higher doses

The findings demonstrate that, although GLP-1 agonists can be effective in lowering haemoglobin A1c and fasting plasma glucose levels, higher doses of these medications significantly increase the risk of gastrointestinal issues

It is essential to consult with a qualified healthcare provider or physician for any inquiries related to a medical condition, treatment, or before initiating any new healthcare routines